Your browser doesn't support javascript.
loading
Differential platelet levels affect response to taxane-based therapy in ovarian cancer.
Bottsford-Miller, Justin; Choi, Hyun-Jin; Dalton, Heather J; Stone, Rebecca L; Cho, Min Soon; Haemmerle, Monika; Nick, Alpa M; Pradeep, Sunila; Zand, Behrouz; Previs, Rebecca A; Pecot, Chad V; Crane, Erin King; Hu, Wei; Lutgendorf, Susan K; Afshar-Kharghan, Vahid; Sood, Anil K.
Affiliation
  • Bottsford-Miller J; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Choi HJ; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dalton HJ; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Stone RL; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cho MS; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Haemmerle M; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nick AM; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pradeep S; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zand B; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Previs RA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pecot CV; Department of Molecular Therapeutics, University of North Carolina Lineberger Comprehensive Cancer Center.
  • Crane EK; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hu W; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lutgendorf SK; Department of Psychology, Obstetrics and Gynecology, and Urology, University of Iowa, Iowa City, Iowa.
  • Afshar-Kharghan V; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sood AK; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center,
Clin Cancer Res ; 21(3): 602-10, 2015 Feb 01.
Article in En | MEDLINE | ID: mdl-25473001
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Platelet Count / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Platelet Count / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2015 Document type: Article